1 – 10 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Updated appropriate use criteria for amyloid and tau PET : A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
- Contribution to journal › Scientific review
-
Mark
Neurofilament, but not Alzheimer disease biomarkers in the acute phase correlate with cognitive performance after cardiac arrest
- Contribution to journal › Article
-
Mark
Updated Appropriate Use Criteria for Amyloid and Tau PET : A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
- Contribution to journal › Article
-
Mark
Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings : A systematic review and meta-analysis
- Contribution to journal › Scientific review
-
Mark
Hyperspectral retinal imaging to detect Alzheimer’s disease in a memory clinic setting
- Contribution to journal › Article
- 2024
-
Mark
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease
- Contribution to journal › Scientific review
-
Mark
Prospective evaluation of the relationship between cognition and recovery outcomes after cardiac arrest
- Contribution to journal › Article
-
Mark
Factors associated with self-rated health in people with late-stage parkinson’s and cognitive impairment
- Contribution to journal › Article
-
Mark
Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression : observational analysis
- Contribution to journal › Article
-
Mark
The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson’s Disease
- Contribution to journal › Article
